ClinVar, Controversy, and the Case for Change at Myriad Genetics. Demystifying Genetics with Susan Manley

Demystifying Genetics

Myriad Genetics has had a contentious reputation, especially amongst the genetic counseling community in North America. This is mainly due to Myriad's involvement in the patenting of the BRCA genes in the USA and Myriad's decision to not submit data to ClinVar unlike most other genetic testing laboratories.
Myriad Genetics has a suite of fantastic, industry leading genetic tests, that help thousands of people each month. However, a lab is more than it's tests. Cultural change may be needed, but one bright star at Myriad is genetic counselor Susan Manley, the Senior Vice President of Medical Services.
Join us as we uncover Myriad's evolving stance on ClinVar, a public database for genetic variant information. From initial reluctance to eventual contribution, discover the driving forces behind this monumental decision. Learn about the challenges faced by Myriad, the strategies used to reclassify variants, and the complexities they grapple with when explaining uncertain results to patients. As we wrap up, Susan offers her forward-looking views on the future of genetic medicine, leaving us with plenty to ponder. Embark on this enlightening exploration with us, and prepare to see genetic medicine through a new lens.
https://myriad.com/myriad-genetics-blog/my-myriad-susan/
https://myriad.com/

Support the show

Demystifying Genetics is sponsored by TrakGene
https://www.trakgene.com/

فصل ها

1. Controversial Gene Patenting and Myriad's Involvement (00:00:00)

2. Gene Patents and Their Implications (00:08:56)

3. Myriad's Decision on Contributing to ClinVar (00:20:50)

4. The Changing Landscape of Genetic Medicine (00:31:11)